Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.63 |
| ▸ | DRD4 | P21917 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | DRD2 | P14416 | 1/20 | 0.59 |
| ▸ | DRD3 | P35462 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.58 |
| ▸ | ACHE | P22303 | 2/20 | 0.57 |
| ▸ | BACE1 | P56817 | 2/20 | 0.57 |
| ▸ | BCHE | P06276 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4133414 | 0.88 | SIGMAR1 (0.67) | SIGMAR1DRD4KMT2ADRD2DRD3 | |
| SCHEMBL3164487 | 0.87 | SIGMAR1 (0.74) | SIGMAR1DRD4KMT2ADRD2DRD3 | |
| SCHEMBL8553564 | 0.84 | DRD4 (0.70) | SIGMAR1DRD4KMT2ADRD2ACHE | |
| Hydrochloric Acid SCHEMBL27514643 | 0.82 | DRD4 (0.56) | SIGMAR1DRD4 | |
| SCHEMBL17610278 | 0.82 | BCHE (0.62) | SIGMAR1DRD4KMT2ADRD2DRD3 | |
| SCHEMBL3635817 | 0.81 | KMT2A (0.56) | SIGMAR1DRD4KMT2ADRD2DRD3 | |
| SCHEMBL7393471 | 0.81 | DRD4 (0.67) | SIGMAR1DRD4KMT2ADRD2DRD3 | |
| SCHEMBL1781392 | 0.81 | DRD4 (0.67) | SIGMAR1DRD4KMT2ADRD2DRD3 | |
| SCHEMBL7500995 | 0.81 | DRD4 (0.67) | SIGMAR1DRD4KMT2ADRD2DRD3 | |
| SCHEMBL8185713 | 0.81 | CYP2C19 (0.62) | SIGMAR1KMT2ADPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200352917-A1 | MEDICATED SPRAY FOR TREATMENT OF SUBSTANCE ABUSE, OVERDOSE, ADDICTION AND IMPULSE CONTROL DISORDERS | GOOBERMAN LANCE L (US) | 2020-11-12 | — | — | US | disclosed |